Literature DB >> 22306794

Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.

Jorge M Castellanos1, Lisa M Smith, Paul D Varosy, Christine Dehlendorf, Gregory M Marcus.   

Abstract

BACKGROUND: The American College of Cardiology, the American Heart Association, and the Heart Rhythm Society guidelines provide patient selection criteria for primary prevention implantable cardioverter-defibrillators (ICDs). For unknown reasons, guideline-discordant practice is common.
OBJECTIVE: To determine referring physicians' concordance with the primary prevention ICD guidelines.
METHODS: We mailed a survey regarding ICD guidelines and individual practice characteristics to a random national sample of 3000 physicians selected from the American Medical Association Masterfile-one-third each specializing in family medicine, internal medicine, and general cardiology.
RESULTS: Sixty-four percent with correct contact information responded. Three hundred ninety-five (28%; 95% confidence interval [CI] 25%-30%) respondents never refer patients with the intent of consideration for a primary prevention ICD, including 7% (95% CI 5%-10%) of cardiologists. Two hundred twelve (15%; 95% CI 13%-17%) believe ventricular arrhythmias are required before a primary prevention ICD is indicated; 525 (36%; 95% CI 34%-39%) believe that an ejection fraction of >40% warrants a primary prevention ICD; and 361 (25%; 95% CI 23%-27%) would refer a patient for a primary prevention ICD within 40 days of a myocardial infarction. In multivariate analyses, family practice physicians and physicians residing in the western United States most often provided guideline-discordant answers, while cardiologists and those who refer to an electrophysiologist most often provided guideline-concordant answers. Primary care physicians who manage heart failure patients without referral to a subspecialist were not more likely to provide guideline-concordant answers.
CONCLUSIONS: Answers discordant with the primary prevention ICD guidelines were common, suggesting that referring physician beliefs are an important barrier to appropriate patient referrals for primary prevention ICD implantation.
Copyright © 2012 Heart Rhythm Society. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22306794      PMCID: PMC3355218          DOI: 10.1016/j.hrthm.2012.01.029

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  22 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Medicare coverage of ICDs.

Authors:  Mark B McClellan; Sean R Tunis
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

3.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.

Authors:  Dan D Matlock; Jean S Kutner; Caroline B Emsermann; Sana M Al-Khatib; Gillian D Sanders; L Miriam Dickinson; John S Rumsfeld; Arthur J Davidson; Lori A Crane; Frederick A Masoudi
Journal:  J Card Fail       Date:  2011-02-22       Impact factor: 5.712

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

8.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

9.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

Review 10.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

View more
  9 in total

1.  Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.

Authors:  Allen Hoang; Changyu Shen; James Zheng; Stanley Taylor; William J Groh; Marc Rosenman; Alfred E Buxton; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2014-02-22       Impact factor: 6.343

Review 2.  ICD Implantation Practice Within Europe: How To Explain The Differences Beyond Economy?

Authors:  Baccillieri Maria Stella; Zorzi Alessandro
Journal:  J Atr Fibrillation       Date:  2015-10-31

3.  Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross-sectional study.

Authors:  Mohammad A Zakeri; Nadia Sedri; Golamreza Bazmandegan; Maryam Zakeri; Mohammad Safariyan; Mahlagha Dehghan
Journal:  Health Sci Rep       Date:  2022-06-13

4.  Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.

Authors:  Amy Leigh Miller; Kensey Gosch; Stacie L Daugherty; Saif Rathore; Pamela N Peterson; Eric D Peterson; P Michael Ho; Paul S Chan; David E Lanfear; John A Spertus; Tracy Y Wang
Journal:  Am Heart J       Date:  2013-09-05       Impact factor: 4.749

Review 5.  The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis.

Authors:  Attila Roka; Mark H Schoenfeld
Journal:  J Interv Card Electrophysiol       Date:  2012-12-15       Impact factor: 1.900

6.  Factors influencing utilization of the primary prevention implantable defibrillator.

Authors:  Lin Zhang; Kumar Narayanan; Harpriya Chugh; Takahiro Shiota; Zhi-Jie Zheng; Sumeet S Chugh
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Physicians' knowledge and attitudes in Saudi Arabia regarding implantable cardiac defibrillators.

Authors:  Tariq Alhogbani; Fuad A Awwad; Abdullah S Aljasser
Journal:  J Saudi Heart Assoc       Date:  2017-06-08

8.  Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study.

Authors:  Ji Hyun Lee; So Ryoung Lee; Eue Keun Choi; Jaehan Jeong; Hyung Deuk Park; So Jeong You; Sang Soo Lee; Seil Oh
Journal:  Korean Circ J       Date:  2019-04-09       Impact factor: 3.243

Review 9.  Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians.

Authors:  Inder Anand
Journal:  Am J Cardiovasc Drugs       Date:  2018-10       Impact factor: 3.571

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.